» Articles » PMID: 19129459

Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness

Abstract

To better understand the components of an effective immune response to human immunodeficiency virus (HIV), the CD8(+) T-cell responses to HIV, hepatitis C virus (HCV), and cytomegalovirus (CMV) were compared with regard to frequency, immunodominance, phenotype, and interleukin-2 (IL-2) responsiveness. Responses were examined in rare patients exhibiting durable immune-mediated control over HIV, termed long-term nonprogressors (LTNP) or elite controllers, and patients with progressive HIV infection (progressors). The magnitude of the virus-specific CD8(+) T-cell response targeting HIV, CMV, and HCV was not significantly different between LTNP and progressors, even though their capacity to proliferate to HIV antigens was preserved only in LTNP. In contrast to HIV-specific CD8(+) T-cell responses of LTNP, HLA B5701-restricted responses within CMV pp65 were rare and did not dominate the total CMV-specific response. Virus-specific CD8(+) T cells were predominantly CD27(+)45RO(+) for HIV and CD27(-)45RA(+) for CMV; however, these phenotypes were highly variable and heavily influenced by the degree of viremia. Although IL-2 induced significant expansions of CMV-specific CD8(+) T cells in LTNP and progressors by increasing both the numbers of cells entering the proliferating pool and the number of divisions, the proliferative capacity of a significant proportion of HIV-specific CD8(+) T cells was not restored with exogenous IL-2. These results suggest that immunodominance by HLA B5701-restricted cells is specific to HIV infection in LTNP and is not a feature of responses to other chronic viral infections. They also suggest that poor responsiveness to IL-2 is a property of HIV-specific CD8(+) T cells of progressors that is not shared with responses to other viruses over which immunologic control is maintained.

Citing Articles

Investigating population-level immunosenescence: From bench to bedside.

Cunha L, Valsecchi V, Ward L Front Immunol. 2022; 13:949928.

PMID: 36059504 PMC: 9428264. DOI: 10.3389/fimmu.2022.949928.


Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control.

Perdomo-Celis F, Passaes C, Monceaux V, Volant S, Boufassa F, De Truchis P J Clin Invest. 2022; 132(11).

PMID: 35380989 PMC: 9151687. DOI: 10.1172/JCI157549.


HIV-Specific CD8 T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue.

Reuter M, Del Rio Estrada P, Buggert M, Petrovas C, Ferrando-Martinez S, Nguyen S Cell Rep. 2017; 21(12):3458-3470.

PMID: 29262326 PMC: 5764192. DOI: 10.1016/j.celrep.2017.11.075.


T Regulatory Cell Induced Foxp3 Binds the IL2, IFNγ, and TNFα Promoters in Virus-Specific CD8 T Cells from Feline Immunodeficiency Virus Infected Cats.

Wang Y, Nag M, Tuohy J, De Paris K, Fogle J AIDS Res Hum Retroviruses. 2017; 34(3):269-276.

PMID: 29037051 PMC: 5863085. DOI: 10.1089/AID.2017.0187.


Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Zuniga E, Macal M, Lewis G, Harker J Annu Rev Virol. 2016; 2(1):573-97.

PMID: 26958929 PMC: 4785831. DOI: 10.1146/annurev-virology-100114-055226.


References
1.
Davey Jr R, Murphy R, Graziano F, Boswell S, Pavia A, Cancio M . Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. JAMA. 2000; 284(2):183-9. DOI: 10.1001/jama.284.2.183. View

2.
Lauer G, Nguyen T, Day C, Robbins G, Flynn T, McGowan K . Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol. 2002; 76(6):2817-26. PMC: 135971. DOI: 10.1128/jvi.76.6.2817-2826.2002. View

3.
Mandelboim O, Reyburn H, Vales-Gomez M, Pazmany L, Colonna M, Borsellino G . Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med. 1996; 184(3):913-22. PMC: 2192787. DOI: 10.1084/jem.184.3.913. View

4.
Callan M, Tan L, Annels N, Ogg G, Wilson J, OCallaghan C . Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med. 1998; 187(9):1395-402. PMC: 2212279. DOI: 10.1084/jem.187.9.1395. View

5.
Migueles S, Connors M . Frequency and function of HIV-specific CD8(+) T cells. Immunol Lett. 2001; 79(1-2):141-50. DOI: 10.1016/s0165-2478(01)00276-0. View